CLBT

CLBT P/E Ratio
P/E Ratio as of Oct 30, 2026: 52.39
Average49.56
Median49.03
Minimum46.70
Maximum52.95
52.39
5.26 (11.16%)past month
The P/E ratio for CLBT is 52.39 as of Oct 30, 2026. This represents a increase of 17.78% compared to its 12-month average P/E ratio of 44.48. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Cellebrite DI Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cellebrite DI Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cellebrite DI Ltd to industry peers.
Cellebrite DI Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cellebrite DI Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cellebrite DI Ltd to industry peers.
CLBT P/E Ratio Insights
See Cellebrite DI Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CLBT
Order type
Buy in
Order amount
Est. shares
0 shares
CLBT P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $11.14 | 48.04 |
| Sep 1, 2026 | $11.85 | 51.10 |
| Aug 3, 2026 | $15.07 | 52.88 |
| Jul 1, 2026 | $15.45 | 54.21 |
| Jun 1, 2026 | $15.87 | 55.68 |
| May 1, 2026 | $13.35 | 42.87 |
| Apr 1, 2026 | $13.88 | 44.57 |
| Mar 2, 2026 | $13.50 | 43.35 |
| Feb 2, 2026 | $14.90 | 48.57 |
| Jan 2, 2026 | $17.84 | 58.15 |
CLBT End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 52.39 | -11.11% |
| 2025 | 58.94 | -514.78% |
| 2024 | -14.21 | -47.27% |
| 2023 | -26.95 | -621.28% |
| 2022 | 5.17 | -85.49% |
| 2021 | 35.64 | — |
FAQs About Cellebrite DI Ltd (CLBT) P/E ratio
The latest P/E ratio of CLBT is 52.39, as of Oct 30, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Cellebrite DI Ltd’s last 12-month average P/E ratio is 44.48, compared to its current P/E ratio of 52.39. This reflects a increase of 17.78%.
Cellebrite DI Ltd’s current P/E ratio of 52.39 is higher than its last 12-month average P/E of 44.48. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Cellebrite DI Ltd’s average P/E ratio over the last 3 years is 1.02. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Cellebrite DI Ltd’s average P/E ratio over the last 5 years is 3.16. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
CLBT P/E Ratio Insights
See Cellebrite DI Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CLBT
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.